blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2753935

EP2753935 - DIAGNOSTIC ASSAY TO PREDICT CARDIOVASCULAR RISK [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  09.02.2018
Database last updated on 31.08.2024
FormerExamination is in progress
Status updated on  02.11.2017
Most recent event   Tooltip09.02.2018Application deemed to be withdrawnpublished on 14.03.2018  [2018/11]
Applicant(s)For all designated states
GENWAY BIOTECH, INC.
6777 Nancy Ridge Drive
San Diego CA 92121 / US
For all designated states
Mental Health Research Institute
6525 Belcrest Road
Suite 700
Hyattsville, MD 20782 / US
For all designated states
Emory University
Office of Technology Transfer 1599 Clifton Road, NE 4th Floor
Atlanta, GA 30322 / US
[2014/29]
Inventor(s)01 / SIKORA, Sergey
6777 Nancy Ridge Drive
San Diego, CA 92121 / US
02 / EPSTEIN, Stephen
6525 Belcrest Road
Suite 700
Hyattsville, MD 20782 / US
03 / QUYYUMI, Arshed, A.
Emory Clinical Cardiovascular Research Institute
1462 Clifton Road N.E.
Suite 507
Atlanta, GA 30322 / US
 [2014/29]
Representative(s)Zacco Sweden AB
P.O. Box 5581
Löjtnantsgatan 21
114 85 Stockholm / SE
[N/P]
Former [2014/29]Höglund, Lars
Zacco Sweden AB
P.O. Box 5581
114 85 Stockholm / SE
Application number, filing date12709223.701.03.2012
WO2012US27354
Priority number, dateUS201161532012P07.09.2011         Original published format: US 201161532012 P
[2014/29]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013036285
Date:14.03.2013
Language:EN
[2013/11]
Type: A1 Application with search report 
No.:EP2753935
Date:16.07.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 14.03.2013 takes the place of the publication of the European patent application.
[2014/29]
Search report(s)International search report - published on:EP14.03.2013
ClassificationIPC:G01N33/68
[2014/29]
CPC:
G01N33/6893 (EP,CN,US); G01N33/50 (US); G01N33/5091 (US);
G01N33/53 (US); G01N33/86 (US); C07K14/47 (US);
C07K14/75 (US); G01N2333/4737 (US); G01N2333/75 (US);
G01N2800/324 (EP,CN,US); G01N2800/325 (US); G01N2800/50 (US);
G01N2800/52 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/29]
TitleGerman:DIAGNOSTISCHER ASSAY ZUR VORHERSAGE VON KARDIOVASKULÄREM RISIKO[2014/29]
English:DIAGNOSTIC ASSAY TO PREDICT CARDIOVASCULAR RISK[2014/29]
French:DOSAGE DE DIAGNOSTIC POUR LA PRÉDICTION D'UN RISQUE CARDIOVASCULAIRE[2014/29]
Entry into regional phase06.03.2014National basic fee paid 
06.03.2014Designation fee(s) paid 
06.03.2014Examination fee paid 
Examination procedure06.03.2014Examination requested  [2014/29]
23.10.2014Amendment by applicant (claims and/or description)
08.01.2015Despatch of a communication from the examining division (Time limit: M06)
20.07.2015Reply to a communication from the examining division
27.11.2015Despatch of a communication from the examining division (Time limit: M06)
06.06.2016Reply to a communication from the examining division
03.10.2017Application deemed to be withdrawn, date of legal effect  [2018/11]
03.11.2017Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2018/11]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  08.01.2015
Fees paidRenewal fee
06.03.2014Renewal fee patent year 03
04.09.2015Renewal fee patent year 04
26.09.2016Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.03.201504   M06   Fee paid on   04.09.2015
31.03.201605   M06   Fee paid on   26.09.2016
31.03.201706   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO2010114514  (AMDL INC [US], et al) [A] 1-46;
 [XP]  - EAPEN DANNY J ET AL, "Aggregate Risk Score Based on Markers of Inflammation, Immunity, and Thrombosis is an Independent Predictor of Adverse Cardiovascular Outcomes", CIRCULATION, & SCIENTIFIC SESSIONS OF THE AMERICAN-HEART-ASSOCIATION/RESUSCITATION SCIENCE SYMPOSIUM; ORLANDO, FL, USA; NOVEMBER 12 -16, 2011, (201111), vol. 124, no. 21, Suppl. S, page HTTP://CI, XP009158886 [XP] 1-46 * the whole document *
 [A]  - ASPASIA SOULTATI ET AL, "Predicting utility of a model for end stage liver disease in alcoholic liver disease.", WORLD JOURNAL OF GASTROENTEROLOGY, (20060701), vol. 12, no. 25, ISSN 1007-9327, pages 4020 - 4025, XP055025800 [A] 1-46

DOI:   http://dx.doi.org/10.3748/wjg.v12.i25.4020
 [A]  - IAN B.A MENOWN ET AL, "Prediction of Recurrent Events by D-Dimer and Inflammatory Markers in Patients with Normal Cardiac Troponin I (PREDICT) study", AMERICAN HEART JOURNAL, (20030601), vol. 145, no. 6, doi:10.1016/S0002-8703(03)00169-8, ISSN 0002-8703, pages 986 - 992, XP055025775 [A] 1-46

DOI:   http://dx.doi.org/10.1016/S0002-8703(03)00169-8
Examination   - Andrea L. Small-Howard ET AL, "ADVANTAGES OF THE AMDL-ELISA DR-70 (FDP) ASSAY OVER CARCINOEMBRYONIC ANTIGEN (CEA) FOR MONITORING COLORECTAL CANCER PATIENTS", JOURNAL OF IMMUNOASSAY AND IMMUNOCHEMISTRY, US, (20100329), vol. 31, no. 2, doi:10.1080/15321811003617438, ISSN 1532-1819, pages 131 - 147, XP055230028

DOI:   http://dx.doi.org/10.1080/15321811003617438
by applicantWO2010114514
    - AM HEART J., (20081022), vol. 157, no. 1, pages 111 - 117
    - PRINCE, H.E., BIOMARKERS, (200511), vol. 10, no. 1, pages 44 - 49
    - RAJDEV; SHARP, TOXICOLOGIC PATHOLOGY, (2000), vol. 28, no. 1, pages 105 - 112
    - ZHOU ET AL., CIRCULATION, (2004), vol. 110, pages 207 - 213
    - ROBERTS ET AL., CLINICAL CHEMISTRY, (2000), vol. 46, no. 4, pages 461 - 68
    - SHINE B ET AL., CLIN CHIM, ACTA, (1981), vol. 117, pages 13 - 23
    - ROSENBAUM, P.R.; RUBIN, D.B., BIOMETRIKA, vol. 70, no. 1, (1983), pages 41 - 55, URL: en.wikipedia.org/wiki/Propensity-score-matching
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.